123 results
Page 5 of 7
8-K
EX-99.2
gprv r1md
20 Nov 19
Other Events
7:05am
8-K
EX-99.1
k9pnu1m81vnwug
20 Nov 19
Other Events
7:05am
8-K
EX-99.1
fv89qknim5b vfz4
3 Oct 19
Other Events
7:15am
8-K
EX-99.2
ju484s89chjn 3uw
27 Sep 19
Other Events
10:15am
8-K
EX-99.1
is3v3ung
12 Aug 19
Other Events
7:05am
8-K
EX-99.1
yb60 2x6zzzja
8 Aug 19
Aravive Announces Executive Management Transition Plan
5:06pm
424B5
2udr kyfo
26 Mar 19
Prospectus supplement for primary offering
6:25am
8-K
EX-99.1
nacxynk9m
7 Mar 19
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
t0221iiji349wpp
5 Feb 19
Regulation FD Disclosure
7:01am
8-K
EX-99.1
s9lr 3it9
13 Nov 18
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
7:10am
S-4
92j3 5oaiv
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm
425
8hd8mgicb812rt828
10 Jul 18
Business combination disclosure
4:28pm